DK0828711T3 - Hidtil ukendt fremgangsmåde til fremstilling af ropivacainhydrochloridmonohydrat - Google Patents

Hidtil ukendt fremgangsmåde til fremstilling af ropivacainhydrochloridmonohydrat

Info

Publication number
DK0828711T3
DK0828711T3 DK96914488T DK96914488T DK0828711T3 DK 0828711 T3 DK0828711 T3 DK 0828711T3 DK 96914488 T DK96914488 T DK 96914488T DK 96914488 T DK96914488 T DK 96914488T DK 0828711 T3 DK0828711 T3 DK 0828711T3
Authority
DK
Denmark
Prior art keywords
hydrochloride monohydrate
hitherto unknown
ropivacaine hydrochloride
unknown method
preparing
Prior art date
Application number
DK96914488T
Other languages
Danish (da)
English (en)
Inventor
Peter Jaksch
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK0828711T3 publication Critical patent/DK0828711T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)
DK96914488T 1995-05-16 1996-04-30 Hidtil ukendt fremgangsmåde til fremstilling af ropivacainhydrochloridmonohydrat DK0828711T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9501808A SE9501808D0 (sv) 1995-05-16 1995-05-16 New process
PCT/SE1996/000563 WO1996036606A1 (fr) 1995-05-16 1996-04-30 Nouveau procede de preparation de monohydrate d'hydrochlorure de ropivacaine

Publications (1)

Publication Number Publication Date
DK0828711T3 true DK0828711T3 (da) 2002-02-11

Family

ID=20398325

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96914488T DK0828711T3 (da) 1995-05-16 1996-04-30 Hidtil ukendt fremgangsmåde til fremstilling af ropivacainhydrochloridmonohydrat

Country Status (34)

Country Link
US (1) US5959112A (fr)
EP (1) EP0828711B1 (fr)
JP (1) JP3079112B2 (fr)
KR (1) KR100425232B1 (fr)
CN (1) CN1121388C (fr)
AR (1) AR002737A1 (fr)
AT (1) ATE207900T1 (fr)
AU (1) AU696875B2 (fr)
BR (1) BR9608820A (fr)
CA (1) CA2219308C (fr)
CZ (1) CZ290576B6 (fr)
DE (1) DE69616543T2 (fr)
DK (1) DK0828711T3 (fr)
EE (1) EE03394B1 (fr)
ES (1) ES2166888T3 (fr)
HK (1) HK1009805A1 (fr)
HU (1) HU221793B1 (fr)
IL (1) IL118178A (fr)
IN (1) IN185146B (fr)
IS (1) IS1832B (fr)
MY (1) MY115018A (fr)
NO (1) NO309035B1 (fr)
NZ (1) NZ308249A (fr)
PL (1) PL184767B1 (fr)
PT (1) PT828711E (fr)
RU (1) RU2167153C2 (fr)
SA (1) SA96160764B1 (fr)
SE (1) SE9501808D0 (fr)
SK (1) SK281812B6 (fr)
TR (1) TR199701362T1 (fr)
TW (1) TW340841B (fr)
UA (1) UA46770C2 (fr)
WO (1) WO1996036606A1 (fr)
ZA (1) ZA963545B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2222614T3 (es) 1997-11-12 2005-02-01 Mitsubishi Chemical Corporation Derivados de purina y medicina que los contiene como ingrediente activo.
DE60006663T2 (de) 1999-05-11 2004-10-07 Mitsubishi Chem Corp Dihydrat eines purinderivates, medikamente die dieses als aktiven wirkstoff enthalten und zwischenprodukte zu dessen herstellung
AU1037701A (en) * 1999-10-20 2001-04-30 Smithkline Beecham Plc Process for the preparation of 4-(fluorophenyl)piperidine esters
BRPI0104491B8 (pt) * 2001-10-10 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda n-(2,6-dimetilfenil)-1-propil-2-piperidinocarboxamida; processo de obtenção dos enantiômeros; mistura não racêmica dos anantiômeros e seu processo de obtenção e composição farmacêutica.
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
WO2009044404A1 (fr) * 2007-10-01 2009-04-09 Ramniwas Goel Procédé de préparation de (s)-ropivacaïne hydrochlorure monohydrate
CN102093284B (zh) * 2010-12-29 2013-05-08 宜昌人福药业有限责任公司 富集哌啶-2-甲酰苯胺类旋光化合物的方法
WO2014009964A1 (fr) * 2012-07-11 2014-01-16 Neon Laboratories Limited Procédé d'enrichissement énantiomerique de 2', 6'-pipécoloxylidide
CN103086954A (zh) * 2013-02-04 2013-05-08 山东省医药工业研究所 一种制备罗哌卡因的方法
CN104003930B (zh) * 2014-06-13 2016-06-08 山东金诃药物研究开发有限公司 一种盐酸罗哌卡因的制备方法
CN113105386B (zh) * 2021-04-10 2022-11-25 河北一品制药股份有限公司 一种盐酸罗哌卡因一水合物工业化的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE341404B (fr) * 1967-05-18 1971-12-27 Sterling Drug Inc
EP0151110B1 (fr) * 1983-08-01 1989-03-01 Astra Läkemedel Aktiebolag 2,6-XYLIDIDE DE L'ACIDE L-N-n-PROPYLPIPECOLIQUE ET SON PROCEDE DE PREPARATION
SE451840B (sv) * 1986-01-03 1987-11-02 Astra Laekemedel Ab Optiskt rent monohydrat av s-(-)-1-propyl-2',6'-pipekoloxylididhydroklorid, sett att framstella denna och farmaceutiska beredningar for lokalbedovning

Also Published As

Publication number Publication date
SK151297A3 (en) 1998-05-06
ES2166888T3 (es) 2002-05-01
IL118178A0 (en) 1996-09-12
CN1189822A (zh) 1998-08-05
AU5783296A (en) 1996-11-29
IN185146B (fr) 2000-11-25
DE69616543T2 (de) 2002-06-27
EP0828711B1 (fr) 2001-10-31
NZ308249A (en) 1998-08-26
AR002737A1 (es) 1998-04-29
JP3079112B2 (ja) 2000-08-21
IS4607A (is) 1997-11-04
KR19990014827A (ko) 1999-02-25
HUP9900327A2 (hu) 1999-05-28
PT828711E (pt) 2002-04-29
NO309035B1 (no) 2000-12-04
CZ345297A3 (cs) 1998-03-18
NO975220L (no) 1997-11-13
KR100425232B1 (ko) 2004-05-20
CA2219308A1 (fr) 1996-11-21
PL184767B1 (pl) 2002-12-31
PL323461A1 (en) 1998-03-30
MY115018A (en) 2003-03-31
US5959112A (en) 1999-09-28
AU696875B2 (en) 1998-09-17
IS1832B (is) 2002-10-30
SA96160764B1 (ar) 2006-07-30
HU221793B1 (hu) 2003-01-28
IL118178A (en) 2003-07-31
CA2219308C (fr) 2007-12-18
RU2167153C2 (ru) 2001-05-20
EE9700301A (et) 1998-06-15
ATE207900T1 (de) 2001-11-15
EP0828711A1 (fr) 1998-03-18
EE03394B1 (et) 2001-04-16
BR9608820A (pt) 1999-06-15
TR199701362T1 (xx) 1998-05-21
HK1009805A1 (en) 1999-06-11
TW340841B (en) 1998-09-21
JPH11505242A (ja) 1999-05-18
SE9501808D0 (sv) 1995-05-16
SK281812B6 (sk) 2001-08-06
NO975220D0 (no) 1997-11-13
ZA963545B (en) 1996-11-18
CZ290576B6 (cs) 2002-08-14
WO1996036606A1 (fr) 1996-11-21
DE69616543D1 (de) 2001-12-06
UA46770C2 (uk) 2002-06-17
CN1121388C (zh) 2003-09-17
HUP9900327A3 (en) 2001-05-28

Similar Documents

Publication Publication Date Title
ID15803A (id) Alat untuk menempatkan alat
KR970001365A (ko) 알킬하이드로겐클로로실란의 제조방법
EE04234B1 (et) L-fenüülefriinvesinikkloriidi valmistamise meetod
DK0824517T3 (da) Fremgangsmåde til fremstilling af lercanidipinhydrochlorid
DK0828711T3 (da) Hidtil ukendt fremgangsmåde til fremstilling af ropivacainhydrochloridmonohydrat
EE9600153A (et) Meetod nikotiinhappeamiidi saamiseks
FI962371A (fi) Menetelmä kombinatoristen yhdistekirjastojen valmistamiseksi
NO986098D0 (no) FremgangsmÕte for lokalisering av hydrofoner
DK0839138T3 (da) Fremgangsmåde til fremstilling af N-substituerede 3-hydroxypyrazoler
DK1040121T3 (da) Hidtil ukendt fremgangsmåde til fremstilling af cyclosporinderivater
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK0801070T3 (da) Fremgangsmåde til fremstilling af platinforbindelse
DK0749677T3 (da) Fremgangsmåde til fremskaffelse af data
NO992797D0 (no) FremgangsmÕte for fremstilling av et eter-karboksylatsalt
DE69620944D1 (de) Halbleiter-Prüfmethode
ID26804A (id) Metode untuk menghambat mrp1
DK1155004T3 (da) Fremgangsmåde til krystallisation af N-(4-trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid
FI973235A (fi) Menetelmä IL-6:n vaikutusten inhiboimiseksi
DK0729959T3 (da) Fremgangsmåde til fremstilling af loracarbefmonohydrat
NO20003145D0 (no) FremgangsmÕte for fremstilling av paroxetine-hydroklorid
KR970001321A (ko) 2-피롤리돈의 제조 방법
IS5523A (is) Aðferð til að framleiða ísóprópýl-metýl-[2-(3-n-própoxýfenoxý)-etýl]amín
FI980701A (fi) Menetelmä prosessin kestoajan tarkistamiseksi
DE69821677D1 (de) Halbleiterbaustein und Verfahren zu dessen Herstellung